about
Use of oral bisphosphonates by older adults with fractures and impaired renal functionKlotho and kidney disease.FGF23 associated bone diseases.Young patients and those with a low eGFR benefitted more from denosumab therapy in femoral neck bone mineral density.Vitamin D insufficiency in Brazilian patients with SLE: prevalence, associated factors, and relationship with activity.Interferon alpha gene expression and serum level association with low vitamin D levels in Egyptian female patients with systemic lupus erythematosus.Bisphophonates in CKD patients with low bone mineral density.Dietary Treatment of Metabolic Acidosis in Chronic Kidney Disease.Review on the Utility of Trabecular Bone Score, a Surrogate of Bone Micro-architecture, in the Chronic Kidney Disease Spectrum and in Kidney Transplant Recipients
P2860
Q34220843-850280B5-C53E-437D-B20A-F2F8BFE2A4D2Q35582566-756310A6-FBCD-4B37-AC47-A06624638DE6Q38087548-5CADAD9C-F66C-461C-93C9-14586A61A55DQ38984955-4C7D4433-17CB-4C89-ABFC-0EF08F5E9912Q44449725-78EFECE1-CFB7-4EF0-BA62-CC219988156FQ46173910-E5B8536E-85E0-4F76-8D47-01BB94DCF502Q54313739-B0B12B9C-EC8C-488B-BF90-D1EA3DBF8F4AQ55382841-EA05E059-080A-4D3E-90E3-7C0FDC741888Q57492364-F552A56F-FB0E-4963-A0CF-9EC526549498
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management of osteoporosis in CKD Stages 3 to 5.
@en
Management of osteoporosis in CKD Stages 3 to 5.
@nl
type
label
Management of osteoporosis in CKD Stages 3 to 5.
@en
Management of osteoporosis in CKD Stages 3 to 5.
@nl
prefLabel
Management of osteoporosis in CKD Stages 3 to 5.
@en
Management of osteoporosis in CKD Stages 3 to 5.
@nl
P1476
Management of osteoporosis in CKD Stages 3 to 5.
@en
P2093
Lynda A Frassetto
Patricia L Gordon
P304
P356
10.1053/J.AJKD.2010.02.338
P577
2010-05-01T00:00:00Z